John L Spaid Form 4 NATIONAL HEALTH INVESTORS / John L Spaid ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Spaid John L

(Last)

(First)

(Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO

37129

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
CFO/EVP Finance

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								11,279.6372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to buy) 2022	$53.41	02/25/2022		A		18,333		02/25/2022	02/25/2027	Common Stock	18,333	$53.41	18,333	D
Stock Option (Right to buy) 2022	$53.41	02/25/2022		A		18,333		02/25/2023	02/25/2027	Common Stock	18,333	$53.41	18,333	D
Stock Option (Right to buy) 2022	$53.41	02/25/2022		A		18,334		02/25/2024	02/25/2027	Common Stock	18,334	$53.41	18,334	D
Stock Options (Right to Buy) 2-20-18	$64.33							02/20/2018	02/20/2023	Common Stock	7,000		7,000	D
Stock Options (Right to Buy) 2-20-18	$64.33							02/20/2019	02/20/2023	Common Stock	7,000		7,000	D
Stock Options (Right to Buy) 2-20-18	$64.33							02/20/2020	02/20/2023	Common Stock	14,168		14,168	D
Stock Options (Right to Buy) 2019	$79.96							02/21/2019	02/21/2024	Common Stock	15,833		15,833	D
Stock Options (Right to Buy) 2019	$79.96							02/21/2020	02/21/2024	Common Stock	15,833		15,833	D
Stock Options (Right to Buy) 2019	$79.96							02/21/2021	02/21/2024	Common Stock	15,834		15,834	D
Stock Options (Right to Buy) 2-21-2020	$90.79							02/21/2020	02/21/2025	Common Stock	18,333		18,333	D
Stock Options (Right to Buy) 2-21-2020	$90.79							02/21/2021	02/21/2025	Common Stock	18,333		18,333	D
Stock Options (Right to Buy) 2-21-2020	$90.79							02/21/2022	02/21/2025	Common Stock	18,334		18,334	D
Stock Options (Right to Buy) 2-25-2021	$69.2							02/25/2021	02/25/2026	Common Stock	18,333		18,333	D
Stock Options (Right to Buy) 2-25-2021	$69.2							02/25/2022	02/25/2026	Common Stock	18,333		18,333	D
Stock Options (Right to Buy) 2-25-2021	$69.2							02/25/2023	02/25/2026	Common Stock	18,334		18,334	D

Explanation of Responses:

	/s/ John L. Spaid	02/28/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

John L Spaid Form 4NATIONAL HEALTH INVESTORS / John L Spaid ownership change